Trinity Biotech (TRIB) Income from Non-Controlling Interests (2019 - 2020)
Trinity Biotech (TRIB) posted quarterly Income from Non-Controlling Interests of -$1.5 million for Q2 2020, up 72.86% year-on-year from -$848671.2 in Q3 2019, and up 33.98% on a QoQ basis from -$2.2 million in Q1 2020.
Trinity Biotech (TRIB) Income from Non-Controlling Interests (2019 - 2020) Analysis & Trends
Trinity Biotech (TRIB) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$1.5 million the latest figure, recorded in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Trinity Biotech | 113.44 Mn | 108.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -1.47 Mn |
| Mar 31, 2020 | -2.22 Mn |
| Jun 30, 2019 | -5.41 Mn |
| Mar 31, 2019 | -211,000.00 |